Literature DB >> 8185696

HLA and T cell receptor beta-chain DNA polymorphisms identify a distinct subset of patients with pauciarticular-onset juvenile rheumatoid arthritis.

P Charmley1, B S Nepom, P Concannon.   

Abstract

OBJECTIVE: To evaluate and extend upon a reported association of a T cell receptor (TCR) V beta coding region polymorphism with pauciarticular-onset juvenile rheumatoid arthritis (JRA).
METHODS: TCR V beta 6.1 genotypes and haplotypes in JRA and control groups were determined by DNA amplification.
RESULTS: Haplotypes of the V beta 6.1 gene which encode a nonfunctional form of V beta 6.1 were significantly associated with pauciarticular JRA in patients possessing the HLA-DQA1*0101 allele (P = 0.0073).
CONCLUSION: A TCR V beta gene segment in the vicinity of V beta 6.1, possibly V beta 6.1, is apparently involved in the pathogenesis of pauciarticular-onset JRA in DQA1*0101-positive individuals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185696     DOI: 10.1002/art.1780370513

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

Review 1.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  The nonfunctional allele TCRBV6S1B is strongly associated with Helicobacter pylori infection.

Authors:  E Kunstmann; C Hardt; E Elitok; M Harder; S Suerbaum; U Peitz; W Schmiegel; J T Epplen
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  PCR-based genotyping and haplotype analysis of human TCRBV gene segment polymorphisms.

Authors:  P Charmley; P Concannon
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  Immunoprinting: various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients.

Authors:  M Gomolka; H Menninger; J E Saal; E M Lemmel; E D Albert; O Niwa; J T Epplen; C Epplen
Journal:  J Mol Med (Berl)       Date:  1995-01       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.